医学部 産婦人科学

市川 亮子

Ichikawa Ryoko

基本情報

所属
藤田医科大学 医学部 医学科 産婦人科学 助教
学位
学士(医学)

研究者番号
30767306
J-GLOBAL ID
201501000024715597
researchmap会員ID
7000012964

論文

 8
  • Sayaka Otani, Takuma Fujii, Iwao Kukimoto, Naoki Yamamoto, Tetsuya Tsukamoto, Ryoko Ichikawa, Eiji Nishio, Aya Iwata
    Cytokine 120 210-219 2019年8月  査読有り
    Human papillomavirus (HPV) infection can persist in the cervical epithelium without provoking a strong host immune response, leading to the development of cervical cancer. Cytokines, which mediate innate and adaptive immune activities, are secreted in the cervical mucus; however, there is currently no appropriate method for assessing cytokine levels in mucus specimens. Here, we employed multiplexed bead-based immunoassays to examine cytokine levels in cervical mucus using both weighted-volume and total protein concentration methods to adjust for different specimen volumes in individual patients. Out of 18 cytokines initially examined in the primary cohort patient group (n = 28), 14 were detected in more than 10% of the samples. Of these 14 cytokines, expression levels of interferon (IFN)-γ, granulocyte-macrophage colony-stimulating factor (GM-CSF), RANTES, and eotaxin were significantly increased with the disease severity in the secondary cohort patient group (n = 235). We also examined associations between cytokine levels and clinical parameters, such as cytology and HPV genotype. Of the 14 cytokines, granulocyte colony-stimulating factor (G-CSF) was downregulated in HPV-positive specimens. Examination of co-expression patterns of cytokines in relation to HPV infection status revealed that several pairs of cytokines were simultaneously upregulated in HPV-positive cases, including INF-γ and interleukin (IL)-17A, GM-CSF and monocyte chemoattractant protein-1 (MCP-1), GM-CSF and RANTES, IL-17A and RANTES, and MCP-1 and eotaxin. Interestingly, upregulation of GM-CSF and RANTES might reflect a shift in immuno-regulatory cytokines in HPV-positive specimens, potentially associated with more severe cervical neoplasia.
  • Otani S, Fujii T, Kukimoto I, Yamamoto N, Tsukamoto T, Ichikawa R, Nishio E, Iwata A
    Cytokine. 311(1) 55-62 2019年1月  査読有り
  • Satoshi Kawai, Takuma Fujii, Iwao Kukimoto, Hiroya Yamada, Naoki Yamamoto, Makoto Kuroda, Sayaka Otani, Ryoko Ichikawa, Eiji Nishio, Yutaka Torii, Aya Iwata
    Scientific reports 8(1) 7070-7070 2018年5月4日  査読有り
    microRNAs (miRNAs) play important roles in regulation of gene expression during cervical carcinogenesis. We investigated expression profiles of miRNAs in cervical cancer and its precursor lesions by utilizing cervical mucus. Cervical mucus was collected from 230 patients with a normal cervix, cervical intraepithelial neoplasia (CIN), squamous cell carcinoma (SCC), or adenocarcinoma (AD). The levels of miRNA in the mucus were quantified by miRNA array and real-time reverse-transcriptase polymerase chain reaction (RT-PCR). The performance for detecting diseases was statistically analysed. The expression of miRNAs was further validated in the surgical tissues of enrolled patients. Four miRNAs (miR-126-3p, -20b-5p, -451a, and -144-3p) were significantly up-regulated in SCC and AD compared with normal, and their expression levels correlated with disease severity and high-risk human papillomavirus infection. Receiver operating characteristic curve analyses revealed that the area under the curve values for miR-126-3p, -20b-5p, -451a, and -144-3p were 0.89, 0.90, 0.94, and 0.93, respectively, for SCC plus AD compared with normal, showing high accuracy of cancer detection. Real-time RT-PCR analyses confirmed the expression of these four miRNAs in frozen tissues from cervical cancer. miR-126-3p, -20b-5p, -451a, and -144-3p in cervical mucus are promising biomarkers for cervical cancer and high-grade CINs.
  • Kawai S, Ichikawa R, Ueda T, Urano M, Kuroda M, Fujii T
    Fujita Medical Journal 2(4) 77-79 2016年11月  査読有り
    <p>  Ovarian cancer arising from an ovarian endometriotic cyst is frequently encountered; however, this condition has rarely been reported in young patients. We herein report a case of malignant transformation of an ovarian endometriotic cyst in a 26-year-old woman (gravida 0, para 0). During the initial examination at our hospital, ultrasound revealed an endometriotic cyst in the right ovary measuring 49×44×29 mm and an endometriotic cyst in the left ovary measuring 59×53×32 mm with no marked mural nodules on either side.<br> The patient was followed up every 3 months while receiving hormone therapy. At the 6-month follow-up, ultrasound revealed 10-mm mural nodules within the endometriotic cyst of the left ovary. At 10 months, ultrasound revealed that these the mural nodules had enlarged to 15 mm. Pelvic magnetic resonance imaging revealed that the tumor in the left ovary was 64×63 mm in size, which was slightly larger than in the previous scan. The patient underwent laparotomy because of the potential for malignant transformation. Pathological examination revealed clear cell adenocarcinoma. Although malignant transformation of this cancer is rare in women in their 20s, its possibility should be considered; this is true even when cyst enlargement can be controlled during hormone therapy. Magnetic resonance imaging is extremely useful in the diagnosis of malignant transformation.</p>
  • Hasegawa K, Ichikawa R, Kawamura K, Udagawa Y
    Nihon rinsho. Japanese journal of clinical medicine 70 Suppl 4 39-45 2012年6月  査読有り

MISC

 26

講演・口頭発表等

 8